Arlington, MA, United States of America

Takayuki Asahara


Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 250(Granted Patents)


Company Filing History:


Years Active: 1999-2015

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Takayuki Asahara

Introduction

Takayuki Asahara is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of angiogenesis regulation, holding a total of 5 patents. His work focuses on enhancing and inhibiting blood vessel formation, which has important implications for medical treatments.

Latest Patents

Asahara's latest patents include innovative compositions and methods for regulating angiogenesis. These methods utilize endothelial cell (EC) progenitors to either enhance angiogenesis or deliver angiogenesis modulators to specific locations in patients. This approach can be particularly beneficial in treating conditions that require targeted blood vessel formation. Additionally, his inventions aim to induce reendothelialization of injured blood vessels, thereby reducing restenosis by inhibiting smooth muscle cell proliferation.

Career Highlights

Throughout his career, Takayuki Asahara has worked with esteemed organizations such as St. Elizabeth's Medical Center of Boston, Inc. and Caritas St. Elizabeth's Medical Center of Boston, Inc. His experience in these institutions has allowed him to apply his innovative ideas in practical medical settings.

Collaborations

Asahara has collaborated with prominent figures in the field, including Jeffrey M. Isner and Douglas W. Losordo. These partnerships have furthered his research and contributed to advancements in angiogenesis regulation.

Conclusion

Takayuki Asahara's work in the field of angiogenesis regulation showcases his innovative spirit and dedication to improving medical treatments. His patents and collaborations highlight the importance of his contributions to science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…